BillionToOne Launches Northstar Origin Liquid Biopsy Test
Menlo Park, California, USA, September 1, 2026 BillionToOne has launched Northstar Origin™, a new liquid biopsy add-on test designed...
Real-World Evidence
Advertisement
CytoSorbents Advances DrugSorb-ATR FDA Regulatory Path
Princeton, New Jersey, USA, September 2, 2026 CytoSorbents Corporation has announced new real-world clinical data showing that use of...
Fresenius Medical Care Reports Lower Mortality With HDF
BAD HOMBURG, GERMANY, Aug 27, 2026 Fresenius Medical Care has announced the publication of a large multinational real-world evidence...
Eli Lilly Links Zepbound to Lower Healthcare Costs
Zepbound Use Associated With Lower Healthcare Costs INDIANAPOLIS, Aug. 26, 2026 — Eli Lilly and Company announced new real-world...
Curavit Expands Global Clinical Trial Capabilities
BOSTON, August 18, 2026 Curavit Clinical Research, a next-generation clinical research organization (CRO) and Remote Clinical Site, announced the...
Advertisements
AsymBio Secures $184 Million to Expand Global CDMO Growth
Shanghai, China, August 4, 2026 AsymBio, the biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem...
Dexcom Selected as First Participant in FDA TEMPO Pilot Program
San Diego, July 22, 2026 Dexcom announced that it has become the first company selected by the U.S. Food...
Samsung Bioepis and Harrow Strengthen SB11 Clinical Evidence
INCHEON, South Korea & NASHVILLE, Tenn., July 20, 2026 Samsung Bioepis Co., Ltd. and Harrow, Inc. have presented positive...
Supernus Marks Five Years of Qelbree FDA Approval with Continued Growth in ADHD Treatment
ROCKVILLE, Md., July 14, 2026 Supernus Pharmaceuticals celebrated the fifth anniversary of the U.S. Food and Drug Administration (FDA)...
Aethlon Medical Reports Encouraging Hemopurifier Trial Results
SAN DIEGO, California, July 13, 2026 Aethlon Medical, Inc. has announced encouraging interim findings from the second patient cohort...
Advertisement
